Search by

Bachem

Company Headquarters

144 Hauptstrasse, , Bubendorf, BL, 4416, CH

Driving Directions Phone: View Phone

Request more information from Bachem

White Papers / Tech Papers

Maintaining a Resilient Tides Supply Chain Under VUCA Conditions

In today’s unpredictable world, ensuring a resilient pharmaceutical supply chain is more critical than ever.

Released By Bachem

White Papers / Tech Papers

Pioneering Sustainable, Large-Scale Tides Manufacturing

Sustainability has become a top priority in the pharmaceutical manufacturing sector.

Released By Bachem

News Releases

Visit Bachem at the Nordic Life Science Days 2024

Tue, 17 Sept, 2024 - Thu, 19, Sept 2024

Released By Bachem

News Releases

Visit Bachem at the Boulder Peptide Symposium 2024

Mon, 16 Sept, 2024 - Thu, 19 Sept 2024

Released By Bachem

Sponsored Content

How to assess and reduce Nitrosamine Contamination Risks in Peptide APIs

Recent years have seen drug recalls based on nitrosamine drug substance related impurities (NDSRIs), with medical agencies advising API manufacturers to implement risk assessment and mitigation strategies to meet safety and regulatory requirements. CDMOs often serve as a gatekeeper for potential nitrosamine contamination between starting materials and drug formulation. Join this webinar to learn how […]

Released By Bachem

News Releases

See Bachem at EPS – European Peptide Symposium

Sun, 25 Aug, 2024 - Thu, 29 Aug, 2024

Released By Bachem

News Releases

See Bachem at Peptide Therapeutics Forum Basel

Thu, 22 Aug, 2024 - Fri, 23 Aug, 2024

Released By Bachem

News Releases

See Bachem at Bio Asia-Taiwan 2024

Wed, 24 Jul, 2024 - Sun, 28 Jul, 2024

Released By Bachem

News Releases

Bachem brings scientific expertise to Spring 2024 conferences

Bachem will use all three events to showcase its leading-edge capabilities as a peptide and oligonucleotide manufacturer.

Released By Bachem

Sponsored Content

No More DMF: Greener Solid-Phase Peptide Synthesis With Binary Solvents [WATCH ON-DEMAND]

Learn how the polarity and viscosity profiles of binary solvents can be used to predict their utility for producing different peptides by SPPS.

Released By Bachem

News Releases

[WEBINAR] Large-Scale TIDES Purification With MCSGP Under GMP

Join Bachem for a Virtual Event on Tuesday, December 5th, 2023.

Released By Bachem

Sponsored Content

Back to Stirred Vessels and on to Metric Tons of Oligonucleotides

Scientists seek to discover new production routes when manufacturing limits arise.

Released By Bachem

Case Studies

Leading the Octreotide Scale-Up – A Generics Case Study

Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate Synthesis

Released By Bachem

News Releases

[WEBINAR] Tag-assisted one-pot liquid-phase oligonucleotide synthesis

The webinar will take place on November 15, 2023 at 11:00 AM ET / 8:00 AM PT / 17:00 CET

Released By Bachem

News Releases

Visit Bachem at CPhI Worldwide 2023

Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.

Released By Bachem

Sponsored Content

Peptide Aggregation – A Complex Topic [WATCH ON-DEMAND]

Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.

Released By Bachem

Sponsored Content

High-Resolution Mass Spectrometry of Oligonucleotides – Characterization Made Easy [WATCH ON-DEMAND]

Direct, robust and easy-to-use techniques to fully characterize the nucleotide sequence of highly modified single-stranded RNAs by top down tandem MS.

Released By Bachem

Sponsored Content

Learn About Methods for Making Long and Complex Peptides

The pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies.

Released By Bachem

Sponsored Content

Scalable Oligonucleotide Manufacture with Stirred-Bed Technology [WATCH ON-DEMAND]

Learn how to reach commercial oligonucleotides API production in metric ton range with unbeaten process mass intensity and much more.

Released By Bachem

White Papers / Tech Papers

How to increase sustainability for large-scale peptide API purification

The peptide drug market has experienced significant growth in recent years and is expected to continue its upward trend in the coming years.

Released By Bachem

Sponsored Content

Solid Phase Peptide Synthesis Explained

Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis.

Released By Bachem

Sponsored Content

Manufacturing Complex Peptide APIs

An interview with Sergey Malashikhin of Bachem on what’s behind the manufacturing of complex APIs.

Released By Bachem

Sponsored Content

Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

Continuous chromatography is a promising solution due to its high productivity, improved selectivity, and reduced costs.

Released By Bachem

News Releases

Peptide Aggregation – A Complex Topic

In this webinar, Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.

Released By Bachem

News Releases

Leadership Perspectives: Embracing Equity on International Women’s Day

By 2026, Bachem wants to count a 10% higher proportion of women in its workforce, upper management and regional executive committees as compared to 2020.

Released By Bachem

News Releases

Meet Bachem – Interview with Gilles Parmentier

Gilles Parmentier is a seasoned Sales Manager with extensive experience in the field of peptides.

Released By Bachem

News Releases

Bachem Annual General Meeting 2023

Bachem Holding AG announced today that its Annual General Meeting 2023 has approved all proposals of the Board of Directors.

Released By Bachem

News Releases

[WEBINAR] Scalable Oligonucleotide Manufacture With Stirred-Bed Technology

Wednesday, May 24th, 2023 - 11:00 AM ET / 17:00 AM Europe/Zurich

Released By Bachem

News Releases

TIDES USA 2023

Sunday, May 7th - Wednesday, May 10th, 2023 - All Day Event

Released By Bachem

News Releases

Innovative Approaches for Large-scale Peptide Production

Peptides have the potential to expand the space of “druggable” targets.

Released By Bachem

News Releases

Sustainability at Bachem

Bachem has received a platinum medal for being a sustainable business from EcoVadis, a sustainability rating organization.

Released By Bachem

Literature / Brochures

Bachem in Generics – Leading by Experience

Complex generic APIs are not all created equally

Released By Bachem

News Releases

Inspiring Today’s Youth for Science and Technology

Bachem is pleased to support the SimplyNano project as a partner.

Released By Bachem

News Releases

What Does it Take to Manufacture Oligonucleotides?

Oligonucleotides have emerged as a new drug modality originally targeting rare diseases.

Released By Bachem

News Releases

[WEBINAR] Beyond Automation: Towards a Smart Factory

Airing on Thursday, November 17 and again on Tuesday, November 22.

Released By Bachem

News Releases

A World of Virtual Reality: Entering the Metaverse with Bachem 360

Bachem’s virtual showroom sets industry standards in digital customer experience.

Released By Bachem

White Papers / Tech Papers

Bachem’s Key Ingredients for a Successful Oligonucleotide Drug Development

Bachem drives innovation and invests into new oligo manufacturing capacities to meet the needs of our customers.

Released By Bachem

News Releases

Bachem Expands Presence in Northwestern Switzerland with a New Production Site Planned in Sisslerfel

The acquired site offers space for further expansion steps to increase the production capacity of the Bachem Group.

Released By Bachem

News Releases

Innovative Processes Transforming Oligonucleotide Manufacturing

Bachem invested in a capacity expansion for large-scale production of oligonucleotide APIs

Released By Bachem

News Releases

Beyond Automation: Towards a Smart Factory

Register for Bachem's webinar on Thursday 17th November 2022 - 17:30 Europe / Zurich

Released By Bachem

News Releases

Process-Scale MCSGP Purification of Large Synthetic Molecules

Register now for Bachem's webinar on Thursday, 10th November 2022 - 17:20 - 18:30 Europe/Zurich

Released By Bachem

News Releases

Bachem Expands Presence in Northwestern Switzerland

New production site planned in Sisslerfeld.

Released By Bachem

News Releases

Bachem Signs Large Volume Contracts for Peptides

Two contracts signed with order volumes of CHF 25 million in 2023 and CHF 150 million in 2024.

Released By Bachem

News Releases

[WEBINAR] Towards More Sustainable Procurement

Learn about Bachem's initiatives directed at making their supply chain more sustainable and resilient.

Released By Bachem

News Releases

Interview with Phillip Karbach, COOO/CFO of AMW

We sat down with Philipp Karbach, COO and CFO of AMW, to ask about his experience collaborating with Bachem.

Released By Bachem

Services

Exclusive Services for Cosmetic Peptides

Peptides are popular active ingredients for cosmetic products called cosmeceuticals.

Released By Bachem

News Releases

Bachem’s Journey to Industry 4.0

Industry 4.0 refers to the automation and digitalization of traditional industrial processes through smart technology and integration.

Released By Bachem

Services

Innovation Transforming Oligonucleotide Manufacturing

One of Bachem’s mission is to provide excellence to its customers and be a major player in their success.

Released By Bachem

News Releases

Bachem Enters Strategic Collaboration With Lilly To Manufacture Oligonucleotide-Based Drug Substance

Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology.

Released By Bachem

Literature / Brochures

Bachem – Partner from Research to Marketed API

Bachem is the world’s leading company in the development and production of peptides and oligonucleotides (TIDES).

Released By Bachem

News Releases

No More DMF: Greener Solid-Phase Peptide Synthesis With Binary Solvents

Register now for the webinar on Thursday, May 12th at 5:30pm CET / 8:30am PST.

Released By Bachem

Company Blog

Bachem’s New Facilities For Large-Scale Oligonucleotide Manufacturing Suppliers

Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.

Released By Bachem

News Releases

WEBINAR: The Use of Enzymes in the Production of Peptide API

Learn in this webinar how enzymes enable greener peptide syntheses and what questions appear around the use of enzymes in a GMP setting.

Released By Bachem

Literature / Brochures

Cell-Penetrating Peptides: A Delivery System For Oligonucleotides

Oligonucleotides are very promising and versatile therapeutics for rare and genetic diseases.

Released By Bachem

Company Blog

The thiol-maleimide reaction downside

Secrets of an important byproduct revealed

Released By Bachem

Company Blog

Bachem in Oligonucleotides:

Interview with Seamus White

Released By Bachem

News Releases

BACHEM LAYS FOUNDATIONS FOR COMPANY’S LARGEST PRODUCTION BUILDING ON SWISS NATIONAL FUTURE DAY

World’s most modern production building for peptides and oligonucleotides to be built in Bubendorf Strengthening of the Bubendorf site as a leading center of excellence for the manufacture of complex pharmaceutical active ingredients Clear commitment to Switzerland as a location for business Bachem (SIX: BANB) today laid the foundation stone for the company’s largest production building to […]

Released By Bachem

News Releases

Bachem’s commitment to sustainability

Bachem’s commitment to sustainability Companies that do not just care about their financial bottom line but also about the environment and society are more successful. Today, this fact has reached more than just investors. But investor attention is not the only reason why Bachem is committed to corporate social responsibility (CSR), making sustainability one of its five strategic key […]

Released By Bachem

Literature / Brochures

How are peptides made?

Peptides are very interesting molecules for many applications from therapeutics to cosmetics and diagnostics. But how are they made?

Released By Bachem

Product Releases

Bachem’s Liraglutide: A High-Purity Generic for Diabetes and Weight Loss

Liraglutide, a so-called glucagon like peptide-1 (GLP-1) receptor agonist, is used for the treatment of Type 2 diabetes mellitus and obesity.

Released By Bachem

News Releases

Bachem reports excellent results for the first half-year 2021

Sales of CHF 500 million are now expected for the year 2021.

Released By Bachem

News Releases

Propofol – A Bachem Success Story

The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.

Released By Bachem

News Releases

Bachem and Novo Nordisk Redesign SPPS for Green Chemistry

Replacing gold standard solvents to provide a greener alternative.

Released By Bachem

News Releases

Bachem News & Events

Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.

Released By Bachem

Product Releases

Generic APIs from Bachem

Bachem covers the entire life cycle of an active pharmaceutical ingredient (API). View all of our generic APIs here.

Released By Bachem

Literature / Brochures

Generic APIs Portfolio

With almost 50 years of expertise in peptide and small molecule synthesis, Bachem has an outstanding track record in large-scale manufacturing.

Released By Bachem

White Papers / Tech Papers

Microspheres and Nanoparticles for Peptide Delivery

Navigating The Benefits And Challenges Of Microspheres And Nanoparticles For Peptide Delivery.

Released By Bachem

Related Content